Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care?

AIDS Patient Care and STDs

Volumn 25, Issue 2, 2011, Pages 79-88

  Torian, Lucia V ^a   Wiewel, Ellen W ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; LABORATORY TEST; MALE; MEDICAL CARE; PATIENT CARE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; CONTINUITY OF PATIENT CARE; DISEASE NOTIFICATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; RISK FACTORS; YOUNG ADULT;

EID: 79551658670     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0151     Document Type: Article

References (50)

1. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, December 1, 2009. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Last accessed July 30, 2010).
2. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA Panel. JAMA 2006;296:827-843.
3. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphyocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-954.
4. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194:11-19.
5. Giordano TP, Gifford AL, White AC, Jr. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1439.
6. Quinn TC Wawer MJ, Sewankambo N. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
7. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010;375:2092-2098.
8. Justice A. Prioritizing primary care in HIV: comorbidity, toxicity and demography. Prim Care HIV 2007;14:159-163.
9. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008;47:577-584.
10. Metsch LR, Pereyra M, delRio C, et al. Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health 2004;94:1186-1192.
11. Morin SF, Koester KA, Steward WT, et al. Missed opportunities: prevention with HIV-infected patients in clinical care settings. J Acquir Immune Defic Syndr 2004;36:960-966.
12. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr 2006;41:44-52.
13. Richardson JL, Milan J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS 2004; 18:1179-1186.
14. Naar-King S, Bradford J, Coleman S, Green-Jones M, Cabral H, Tobias C. Retention in care of persons newly diagnosed with HIV: Outcomes of the outreach initiative. AIDS Patient Care STDs 2007;21:S-40-S-48.
15. Gardner LI, Marks G, O'Daniels CM, et al. Implementation and evaluation of a clinic-based behavioral intervention: Positive steps for patients with HIV. AIDS Patient Care STDs 2008;22:627-635.
16. Torian LV, Wiewel EW, Liu K-L, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008;168:1181-1187.
17. Bozzette SA, Berry SH, Duan N, et al. The care of HIVinfected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998;339:1897-1904.
18. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
19. Hirsch MS. Initiating therapy: When to start, what to use. J Infect Dis 2008;197(Suppl 3):S252-S260.
20. Uphold CR, Mkanta WN. Use of health care services among persons living with HIV infection: State of the science and future directions. AIDS Patient Care STDs 2005;19:473-485.
21. Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr 2000;25:115-123.
22. Turner BJ, Cunningham WE, Duan N, et al. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 2000;160:2614-2622.
23. Tobias CR, Cunningham WE, Cabral HD, et al. Living with HIV but without medical care: Barriers to engagement. AIDS Patient Care STDs 2007;21:426-434.
24. Fleishman JA, Gebo KA, Reilly ED. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care 2005;43(Suppl 9);III:40-52.
25. State of New York, Public Health Law Article 21 (1983), Public Health Law Article 27-F - HIV and AIDS Information; Public Health Law Article 21, Title III-HIV Reporting and Partner Notification (1998); Code of Administrative Rules and Regulations, Title 10 Part 63 (2000).
26. Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: Does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 2002;156:471-482.
27. New York City Department of Health and Mental Hygiene, HIV Epidemiology Program, 6th Semiannual Report, October 1, 2006.
28. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, April 7, 2005. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf). (Last accessed July 30, 2010).
29. Pfeiffer MR, Hanna DB, Begier EM, Sepkowitz KA, Torian LV, Sackoff JE. Persistent contribution of substance abuse to excess mortality among persons with AIDS in New York City, 1999-2003 [Abstract #THAC0201]. Toronto: XVI International AIDS Conference, August 13-18, 2006.
30. Cunningham WE, Andersen RM, Katz MH, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Medical Care 1999;37:1270-1281.
31. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C.: National Academy Press, 2003.
32. Giordano TP, Visnegarwala F, White AC, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care 2005;17:773-783.
33. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care 2002;14:S109-S118.
34. Lo W, MacGovern T, Bradford J. Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care 2002;14S1:S45-S57.
35. Sherer R, Stieglitz K, Narra J, et al. HIV multidisciplinary teams work: Support services improve access to and retention in HIV primary care. AIDS Care 2002;14: S31-S44.
36. Wilson IB, Landon BL, Hirschhorn LR, McInnes K, Ding L, Marsden PV. Quality of HIV care provided by nurse practitioners, physician assistants and physicians. Ann Intern Med 2005;143:729-756.
37. Meyerson BE, Klinkenberg WD, Perkins DP, Laffoon BT. Who's in and who's out: Use of primary medical care among people living with HIV. Am J Public Health 2007;97:744-749.
38. Cheever L. Engaging HIV-infected patients in care: Their lives depend on it. Clin Infect Dis 2007;44:1500-1501.
39. Effos RB, Fletcher CV, Gebo K, et al. Workshop of HIV infection and aging: What is known and future research directions. Clin Infect Dis 2008;47:542-553.
40. Ding L, Landon BE, Wilson IB, Hirschhorn LR, Marsden PV, Cleary PD. The quality of care received by HIV patients without a primary provider. AIDS Care 2008;20:35-42.
41. Bradford J. The promise of outreach for engaging and retaining out-of-care persons in HIV medical care. AIDS Patient Care STDs 2007;21:S85-S91.
42. Mugavero MJ, Lin H-Y, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009;48:248-256.
43. Ulett KB, Willig JH, Lin H-Y, et al. The therapeutic implications of timely linkage and early retention in care. AIDS Patient Care STDs 2007;23:41-49.
44. Mimiaga MJ, Reisner SL, Bland S, et al. Health system and personal barriers resulting in decreased utilization of HIV and STD testing services among at-risk black men who have sex with men in Massachusetts. AIDS Patient Care STDs 2009;23:825-835.
45. Sohler NL, Li X, Cunningham CO. Gender disparities in HIV health care utilization among the severely disadvantaged: Can we determine the reasons? AIDS Patient Care STDs 2009;23;9:775-783.
46. Sohler NL, Coleman SM, Cabral H, Naar-King S, Tobias C, Cunningham CO. Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States? AIDS Patient Care STDs 2009;23:837-843.
47. HIV/AIDS Epidemiology and Field Services Semiannual Report 2010; 5:1, April 1, 2010. www.nyc.gov/html/doh/html/dires/hivepi.shtml (Last accessed July 30, 2010).
48. Torian LV, Henning KF, Kellerman SE, Frieden TF. Striving toward comprehensive surveillance of HIV/AIDS: the view from New York City. Pub Health Rep 2007;122:4-6.
49. Granich RM, Gilks CF, Dye C, DeCock KM, Williams BG. Universal voluntary testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.
50. El-Sadr W, Affrunti M, Gamble T, Zerbe A. Antriretroviral therapy: A promising HIV prevention strategy? J Acquir Immune Defic Syndr 2010;55:S116-S121.